Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.

miRecule, a biotechnology company developing RNA therapies, and GBI Biomanufacturing, a CDMO, entered a strategic partnership to advance the development and clinical supply of miRecule’s Antibody-RNA ...

Vantaca, the leading community association management software provider, is thrilled to announce the addition of four distinguished executives to its team: Tom Arnett as Chief Strategy Officer, John ...

The Vision Media team is honored to announce a new relationship with Banner Health, one of the largest non-profit hospital systems in the nation and the largest private employer in ...

NEWTOWN SQUARE, PA, USA and SHANGHAI, China I January 21, 2025 I ArriVent BioPharma, Inc. (Company or ArriVent) (Nasdaq: AVBP) a clinical-stage company dedicated to accelerating the global development ...

SHANGHAI, China I January 9, 2025 I Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced a significant milestone for its proprietary Nectin-4 targeted ADC ...

While the access to combination treatments problem is nothing new, its sheer magnitude means it has, to date, gone unsolved. But now, an initiative spearheaded by Takeda is starting to shift the dial.